Ian Gaudet

Contact Ian

Ian Gaudet

Senior Director, Site Head

Miltenyi Biotec

Dr. Ian Gaudet has been with Miltenyi Biotec since 2016, currently as the Site Head at Miltenyi’s cutting-edge contract development and manufacturing organization (CDMO) in San Jose, CA, leading a team focused on rapid translation of novel cell-based therapies from bench to bedside while enabling long-term commercial feasibility. He studied Bioengineering at the University of California, San Diego, and received his doctorate in Biomedical Engineering jointly from Rutgers University and the University of Medicine and Dentistry of New Jersey. Including his tenure at Miltenyi, Dr. Gaudet has 20 years of experience in biomedical research and development.

Talks About
#cellculture #assaydevelopment

Preferred Locations
#NorthAmerica

Speaking Engagements

2nd Process Development for Cell Therapies Summit

Paid

The 2nd Process Development for Cell Therapies Summit aims to bring together process development experts to discuss and drive efficiencies in early to late-stage development for cell therapies. The success of cell therapy depends on its commercial viability, scalability, and accessibility to patients, making it imperative to optimize processes for

20-22 June 2023

Healthcare

Cell Therapy Manufacturing

Paid

CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automation, closed systems, artificial intelligence, supply chain, and facility design. The meeting takes e

16-17 August 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Ian Gaudet

Senior Director, Site Head

Speaking Engagements

2nd Process Development for Cell Therapies Summit

Cell Therapy Manufacturing